Product Information
PROPAFENONE HCL ER 325 MG CAP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4932 per EA under NDC 16571073706. Its NADAC has been published 256 times since Aug 4, 2021.
Strength
325 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571073706
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PROPAFENONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205956On Market Since
12/16/2020
Pharmacological Classes
Price Statistics
The NADAC for PROPAFENONE HCL ER 325 MG CAP has been published 256 times since Aug 4, 2021, and over the history we have for it it has declined 67.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4932 per EA |
|---|---|
| All-time high | $2.8137 (May 11, 2022) |
| All-time low | $0.4264 (Feb 18, 2026) |
| 52-week high | $0.8529 |
| 52-week low | $0.4264 |
| Median price | $0.9613 |
| Average price | $1.0950 |
| Largest weekly change | +97.6% (Oct 20, 2021) |
| Weeks tracked | 256 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PROPAFENONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PROPAFENONE HCL ER 325 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL ER 325 MG CAP, manufactured by Rising Pharma Holdings Inc., is $0.4932 per EA (NDC 16571073706), effective Jun 24, 2026.
How has the price of PROPAFENONE HCL ER 325 MG CAP changed over time?
Over the history we have for it, the NADAC for PROPAFENONE HCL ER 325 MG CAP has declined 67.3%. It has been tracked across 256 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL ER 325 MG CAP?
Since Aug 4, 2021, the NADAC for PROPAFENONE HCL ER 325 MG CAP has ranged from a low of $0.4264 (Feb 18, 2026) to a high of $2.8137 (May 11, 2022), with a median of $0.9613 per EA.
Are there cheaper alternatives to PROPAFENONE HCL ER 325 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PROPAFENONE HCL ER 325 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures PROPAFENONE HCL ER 325 MG CAP?
PROPAFENONE HCL ER 325 MG CAP (NDC 16571073706) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification